Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T18:03:48.406Z.
Calculation as of: 2026-10-06T18:03:48.406Z.
Quote observation: 2026-10-06T17:59:39.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 270619a8cb927235a94e92f97c71cdfb8fe28fc97d8c39ede642bd89729a24e3
PEG RATIO
N/A
Mobile-health Network Solutions Class A Ordinary Shares
Market Cap
$30263.00
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | $30263.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6254.00 | N/A |
| Akanda Corp. (AKAN)vs › | $61580.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $70965.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109567.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $377001.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
